Clinical trials
Type 2 Diabetes (T2DM) clinical trials
Below are recruiting type 2 diabetes (t2dm) clinical trials, each written for real people, not researchers. We’re tracking 231 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07078565Recruiting
Tai Chi vs. Otago Exercises for Diabetic Nerve Pain
This study compares gentle Tai Chi exercises with a modified Otago exercise program to see which better helps with pain, balance, and movement in people with diabetic nerve pain. If you have had type 2 diabetes for at least 5 years and have chronic nerve pain, this trial may help you find relief and improve your mobility.
Lahore, Punjab ProvinceAges 40–80 - NCT07082114RecruitingPhase 3
Testing a new tablet for type 2 diabetes
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
Yueyang, HunanAges 18–75 - NCT07083154RecruitingPhase 3
Testing a dual-action drug for diabetes and early memory loss
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
Changsha, HunanAges 50–75 - NCT07086989Recruiting
Heart health study for kids with chronic conditions
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
BudapestAges 6–25 - NCT07091162Recruiting
Genetic and CT screening for heart risk in diabetes
This trial uses your genetic risk score and a CT scan of your heart to see if changing how doctors manage your diabetes can lower your risk of heart problems. It is for adults with type 2 diabetes who haven't had heart disease symptoms.
Melbourne, VictoriaAges 40 years+ - NCT07093476RecruitingPhase 3
Adding empagliflozin to improve blood sugar control
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
SeoulAges 19 years+ - NCT07094529Recruiting
Tailored low blood sugar treatment for type 2 diabetes
This study tests a personalized approach to treating low blood sugar (hypoglycemia) in adults with type 2 diabetes. It aims to find out if this tailored treatment plan is practical and helpful for people who take certain diabetes medications (sulfonylureas or insulin).
Ottawa, OntarioAges 18 years+ - NCT07098663RecruitingPhase 2
Study of MKP10241 for weight loss and diabetes control
This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.
Bayswater, VictoriaAges 18–60 - NCT07106879Recruiting
Pre-screening for future metabolic and psychiatric studies
This study does not test a new treatment. It is a pre-screening program to see if you might qualify for future clinical trials on metabolic conditions (like diabetes or weight issues) or psychiatric health (like depression or anxiety). You will be asked some questions and may do some basic health checks to see which future trials could be a good fit for you.
Brooklyn, New YorkAges 18 years+ - NCT07109700RecruitingPhase 2
New injectable study for type 2 diabetes
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
Beijing, Beijing MunicipalityAges 18–65 - NCT07121504Recruiting
Hybrid closed-loop insulin for blood sugar control during surgery
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Changsha, HunanAges 18 years+ - NCT07124923Recruiting
Diabetes support program for adults in primary care
This program tests a new continuous care approach to help people with type 2 diabetes manage their condition better. It is designed for adults who have had diabetes for at least a year and are not already seeing a specialist for diabetes care.
Amposta, TarragonaAges 18–90 - NCT07152509Recruiting
Body Weight's Effect on Activity and Life Quality in Type 2 Diabetes
This study looks at how body weight affects physical activity, balance, and quality of life in people with type 2 diabetes. If you join, the research team will measure your movement abilities and ask about your daily life to see how weight plays a role.
IstanbulAges 18–65 - NCT07163975Recruiting
Complete Pulpotomy vs Root Canal for Diabetic Tooth Infection
This study tests whether a less invasive tooth infection treatment (complete pulpotomy) works as well as a standard root canal for people with type 2 diabetes. It is designed for adults with a specific blood sugar level who have an infected lower back tooth.
Rohtak, HaryanaAges 18–70 - NCT07184775Recruiting
CGM vs finger-stick for type 2 diabetes in pregnancy
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Sewell, New JerseyAges 18 years+ - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT07195045Recruiting
Thai PainPREDICT validation study for diabetes nerve pain
This study tests a tool (PainPREDICT) to predict nerve pain in people with diabetes. It aims to identify those at risk so treatment can start early.
Pathum Wan, BangkokAges 18 years+ - NCT07219602RecruitingPhase 3
Study of obicetrapib and ezetimibe for diabetes and metabolic syndrome
This trial tests a combination medication (obicetrapib plus ezetimibe) taken daily to lower cholesterol and triglycerides in people with type 2 diabetes or metabolic syndrome who are already on standard cholesterol treatment. It may help reduce heart risks.
Sun City West, ArizonaAges 18 years+ - NCT07241221Recruiting
Myo-inositol supplement for diabetes in pregnancy
This study tests whether taking a supplement called myo-inositol (a natural vitamin-like substance) during pregnancy can help manage blood sugar in women with type 2 diabetes. It may improve outcomes for you and your baby.
Singapore, SingaporeAges 21–45 - NCT07241325Recruiting
Emotional health and quality of life in type 2 diabetes
This study looks at how adults with type 2 diabetes feel emotionally and mentally, and how their health affects their daily life. Participants will fill out questionnaires about their mood, well-being, and quality of life.
TaipeiAges 18 years+ - NCT07244003RecruitingPhase 4
Testing metformin with two newer diabetes drugs
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07246421Recruiting
Glucagon resistance in fatty liver and diabetes
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
AarhusAges 30–70 - NCT07250789Recruiting
Brain Care Study: Screen and help for thinking decline in type 2 diabetes
This study screens older adults with type 2 diabetes for early signs of memory or thinking problems, and offers a program to help keep the brain healthy. It aims to find out if a combination of lifestyle changes, mental exercises, and medical support can slow cognitive decline.
CopenhagenAges 65 years+ - NCT07252765Recruiting
Nutritional Drink for Diabetes with Malnutrition Risk
This study is testing whether a special diabetes drink (high in calories, protein, and fiber) helps people with type 2 diabetes who are at risk of malnutrition. If you have diabetes and have been prescribed this drink, you may be able to join.
Santander, CantabriaAges 18 years+
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes (t2dm)?
- Yes. Clin2 currently lists 231 recruiting type 2 diabetes (t2dm) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes (t2dm) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes (t2dm) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.